Vertex Pharmaceuticals (VRTX) is trading down at $546.12 (-2.12%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
No recent news mentioning Vertex Pharmaceuticals in our feed yet.